mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.03 |
mRNA |
purmorphamine |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
SCH-79797 |
CTRPv2 |
pan-cancer |
AAC |
0.074 |
0.03 |
mRNA |
BRD-K55116708 |
CTRPv2 |
pan-cancer |
AAC |
0.076 |
0.03 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.062 |
0.03 |
mRNA |
Sunitinib |
CTRPv2 |
pan-cancer |
AAC |
0.072 |
0.04 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
0.075 |
0.04 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.04 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |